Amanote Research
Register
Sign In
Pin19 - A Cost Comparison of Treating Chronic Hepatitis C Patients With Sofosbuvir-Based Regimens
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1338
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
H. Ru
J. Zhou
Publisher
Elsevier BV
Related search
Cost-Effectiveness of Sofosbuvir-Based Treatments for Chronic Hepatitis C in the US
BMC Gastroenterology
Medicine
Gastroenterology
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia
American Journal of Hematology
Hematology
Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-Based Regimen
Kidney International Reports
Nephrology
Cost-Utility Analysis of Sofosbuvir for Treatment of Genotype2 Chronic Hepatitis C in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Current and Emerging Therapeutic Regimens for Patients With Chronic Hepatitis C Infection
Open Medicine Journal
Interferon-Free Regimens for Chronic Hepatitis C—A Step Forward
Journal of Clinical and Experimental Hepatology
Hepatology
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
Treating Hepatitis C Viral Infection in Patients With Chronic Kidney Disease: When and How
Clinical Liver Disease
Hepatology
